Higher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.
Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.
Promoting domestic medical travel to high-quality providers could improve clinical outcomes and reduce long-term healthcare costs.
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
This study highlights disparities in care for diabetes and hypertension for individuals with serious mental illness compared with the general Medicaid and Medicare populations.
Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.
The latest Joint National Committee guidelines are based on 27 large clinical trials concerning hypertension management. These trials are often discussed in isolation, but their data have never been aggregated into a single source.
Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.
A quality measure reduced antibiotic use for patients with acute bronchitis but led to use of an alternative diagnosis, offsetting most of the observed improvement.
Health systems are important in driving electronic health record adoption in ambulatory clinics, although the uptake of key functionalities varies across systems.
Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
A subanalysis of a successful algorithm-driven primary care–based diabetes disease management program examines the relationships among patient characteristics, labor inputs, and improvement in A1C level.
This study shows that health plans use chronic care management programs as standard components of the overall approach to manage the health of their members.
Pharmacist-provided comprehensive medication management led to a significant difference in emergency department visits and a cost savings of $2.10 to $2.60 for every $1.00 spent relative to a comparator group.
A telehealth nursing program used psychological counseling techniques to improve antipsychotic medication adherence, leading to reduced emergency department utilization in a managed Medicaid population.
Many patients with cancer desire cost discussions with doctors, but those discussions are rare. Nevertheless, cost discussions may lower patient costs-usually without altering treatment.
Treating physicians as your most valued customers: embracing the role of chief happiness officer to drive physician engagement and change management.
A discussion of chronic pain prevalence, care obstacles, and potential opportunities for care improvement within the accountable care organization context at University of California, San Francisco Health.
Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
This article describes the development and capabilities of a Webbased decision support system for care managers working in the context of the chronic care model.